

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 5.41576608 |
| 2 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.34969493 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.18907460 |
| 4 | response to peptidoglycan (GO:0032494) | 5.11663300 |
| 5 | negative thymic T cell selection (GO:0045060) | 4.90791210 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.73266675 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.72908919 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 4.56135597 |
| 9 | sequestering of actin monomers (GO:0042989) | 4.54747175 |
| 10 | thymic T cell selection (GO:0045061) | 4.50617788 |
| 11 | response to interleukin-15 (GO:0070672) | 4.47454362 |
| 12 | positive T cell selection (GO:0043368) | 4.46710878 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46193172 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.44415327 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35758877 |
| 16 | T cell migration (GO:0072678) | 4.33280979 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.32451306 |
| 18 | toxin transport (GO:1901998) | 4.26791289 |
| 19 | muscle filament sliding (GO:0030049) | 4.21920514 |
| 20 | actin-myosin filament sliding (GO:0033275) | 4.21920514 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.16852965 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.16852965 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.16852965 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.16852965 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 4.16852965 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 4.16852965 |
| 27 | detection of other organism (GO:0098543) | 4.13863654 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 4.13444642 |
| 29 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.09424529 |
| 30 | detection of bacterium (GO:0016045) | 4.06610675 |
| 31 | cellular extravasation (GO:0045123) | 4.06325210 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 4.05085523 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 4.04948805 |
| 34 | positive regulation of isotype switching (GO:0045830) | 3.99753776 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.97922658 |
| 36 | T cell selection (GO:0045058) | 3.89636925 |
| 37 | negative regulation of cell killing (GO:0031342) | 3.88798730 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88798730 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.79875394 |
| 40 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68220563 |
| 41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.67173215 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61748146 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.61065331 |
| 44 | respiratory burst (GO:0045730) | 3.52463145 |
| 45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.50639796 |
| 46 | interferon-gamma production (GO:0032609) | 3.50557945 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.49558789 |
| 48 | T cell receptor signaling pathway (GO:0050852) | 3.49294088 |
| 49 | positive regulation of DNA recombination (GO:0045911) | 3.47812200 |
| 50 | neutrophil activation (GO:0042119) | 3.46530067 |
| 51 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43611252 |
| 52 | actin-mediated cell contraction (GO:0070252) | 3.42647225 |
| 53 | mitotic chromosome condensation (GO:0007076) | 3.38586422 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.37959355 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.37227514 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.35919748 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 3.35457498 |
| 58 | DNA replication checkpoint (GO:0000076) | 3.34165994 |
| 59 | positive regulation of mast cell activation (GO:0033005) | 3.33610151 |
| 60 | mitotic metaphase plate congression (GO:0007080) | 3.31317949 |
| 61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.29778709 |
| 62 | leukocyte aggregation (GO:0070486) | 3.29294374 |
| 63 | granulocyte activation (GO:0036230) | 3.28427809 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25631973 |
| 65 | establishment of chromosome localization (GO:0051303) | 3.19611845 |
| 66 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.19492510 |
| 67 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.18235739 |
| 68 | T cell costimulation (GO:0031295) | 3.18133012 |
| 69 | neutrophil mediated immunity (GO:0002446) | 3.16714280 |
| 70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14067235 |
| 71 | detection of biotic stimulus (GO:0009595) | 3.12683374 |
| 72 | regulation of response to interferon-gamma (GO:0060330) | 3.12537962 |
| 73 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12095304 |
| 74 | lymphocyte costimulation (GO:0031294) | 3.11124841 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.10303814 |
| 76 | protein localization to kinetochore (GO:0034501) | 3.09483010 |
| 77 | response to muramyl dipeptide (GO:0032495) | 3.08793678 |
| 78 | macrophage activation (GO:0042116) | 3.07357927 |
| 79 | negative regulation of sodium ion transport (GO:0010766) | 3.07240871 |
| 80 | response to host immune response (GO:0052572) | 3.06909481 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06909481 |
| 82 | ribosomal small subunit assembly (GO:0000028) | 3.05834056 |
| 83 | estrogen biosynthetic process (GO:0006703) | 3.05248891 |
| 84 | germinal center formation (GO:0002467) | 3.04178262 |
| 85 | microglial cell activation (GO:0001774) | 3.03222839 |
| 86 | B cell receptor signaling pathway (GO:0050853) | 3.02930174 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 3.02671247 |
| 88 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.01426305 |
| 89 | positive regulation of B cell mediated immunity (GO:0002714) | 3.01426305 |
| 90 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.99384397 |
| 91 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.97682005 |
| 92 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.97129326 |
| 93 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.96614100 |
| 94 | positive regulation of mast cell degranulation (GO:0043306) | 2.96598964 |
| 95 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.96598964 |
| 96 | positive regulation of humoral immune response (GO:0002922) | 2.96417180 |
| 97 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.95895781 |
| 98 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.95895781 |
| 99 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94614799 |
| 100 | leukocyte degranulation (GO:0043299) | 2.93894213 |
| 101 | regulation of regulated secretory pathway (GO:1903305) | 2.93374234 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 2.91881619 |
| 103 | maturation of SSU-rRNA (GO:0030490) | 2.91166732 |
| 104 | DNA replication initiation (GO:0006270) | 2.90937873 |
| 105 | regulation of isotype switching (GO:0045191) | 2.90648791 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.90421010 |
| 107 | mitotic nuclear envelope disassembly (GO:0007077) | 2.90308730 |
| 108 | CENP-A containing nucleosome assembly (GO:0034080) | 2.90300058 |
| 109 | protein localization to chromosome, centromeric region (GO:0071459) | 2.90228967 |
| 110 | sarcomere organization (GO:0045214) | 2.90092959 |
| 111 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.89960690 |
| 112 | chromatin remodeling at centromere (GO:0031055) | 2.89732128 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.88760178 |
| 114 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.87118029 |
| 115 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.86788846 |
| 116 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86661737 |
| 117 | regulation of chromatin binding (GO:0035561) | 2.86422858 |
| 118 | regulation of tight junction assembly (GO:2000810) | 2.85369274 |
| 119 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82577002 |
| 120 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82577002 |
| 121 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.82073586 |
| 122 | chaperone-mediated protein transport (GO:0072321) | 2.81530591 |
| 123 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.80215085 |
| 124 | metaphase plate congression (GO:0051310) | 2.79989523 |
| 125 | regulation of T cell tolerance induction (GO:0002664) | 2.79463957 |
| 126 | B cell mediated immunity (GO:0019724) | 2.78816502 |
| 127 | definitive hemopoiesis (GO:0060216) | 2.77989842 |
| 128 | negative regulation of granulocyte differentiation (GO:0030853) | 2.77531709 |
| 129 | meiotic cell cycle (GO:0051321) | 2.77295520 |
| 130 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76836943 |
| 131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76613220 |
| 132 | response to host (GO:0075136) | 2.76613220 |
| 133 | response to host defenses (GO:0052200) | 2.76613220 |
| 134 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76344309 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.75874100 |
| 136 | pentose-phosphate shunt (GO:0006098) | 2.75319624 |
| 137 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.75014898 |
| 138 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.74838931 |
| 139 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74324397 |
| 140 | regulation of histone H3-K27 methylation (GO:0061085) | 2.73876238 |
| 141 | negative regulation of innate immune response (GO:0045824) | 2.73486689 |
| 142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73138916 |
| 143 | IMP metabolic process (GO:0046040) | 2.72195381 |
| 144 | tolerance induction (GO:0002507) | 2.70832542 |
| 145 | activation of MAPKKK activity (GO:0000185) | 2.70725857 |
| 146 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70581396 |
| 147 | histone H2A ubiquitination (GO:0033522) | 2.70119490 |
| 148 | actin filament-based movement (GO:0030048) | 2.70053784 |
| 149 | megakaryocyte development (GO:0035855) | 2.68434414 |
| 150 | membrane disassembly (GO:0030397) | 2.68321553 |
| 151 | nuclear envelope disassembly (GO:0051081) | 2.68321553 |
| 152 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.67853025 |
| 153 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.67853025 |
| 154 | negative regulation of meiosis (GO:0045835) | 2.67585454 |
| 155 | activated T cell proliferation (GO:0050798) | 2.66327139 |
| 156 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.65676285 |
| 157 | regulation of helicase activity (GO:0051095) | 2.64479214 |
| 158 | piRNA metabolic process (GO:0034587) | 2.63305687 |
| 159 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.63270250 |
| 160 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.62756882 |
| 161 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.57883416 |
| 162 | skeletal muscle contraction (GO:0003009) | 2.56917353 |
| 163 | positive regulation of cell killing (GO:0031343) | 2.53867685 |
| 164 | regulation of B cell mediated immunity (GO:0002712) | 2.53219918 |
| 165 | nodal signaling pathway (GO:0038092) | 2.52170508 |
| 166 | protein localization to chromosome (GO:0034502) | 2.51749045 |
| 167 | DNA unwinding involved in DNA replication (GO:0006268) | 2.51658363 |
| 168 | DNA strand elongation (GO:0022616) | 2.50538631 |
| 169 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.49784823 |
| 170 | DNA replication-independent nucleosome organization (GO:0034724) | 2.48927513 |
| 171 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.48927513 |
| 172 | microtubule severing (GO:0051013) | 2.44706374 |
| 173 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.41264032 |
| 174 | histone exchange (GO:0043486) | 2.40016944 |
| 175 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.39791321 |
| 176 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.39367560 |
| 177 | histone H2A monoubiquitination (GO:0035518) | 2.39148524 |
| 178 | heterotypic cell-cell adhesion (GO:0034113) | 2.38807023 |
| 179 | IMP biosynthetic process (GO:0006188) | 2.38585660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.36492156 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.25086316 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.13197459 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27028537 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.06343918 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.92035345 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.91462509 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.90647486 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90612576 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.86338790 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.77458945 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76241773 |
| 13 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.71185476 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.69628216 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.66449410 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.62606872 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52212001 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.48561314 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39804163 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.25496842 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.19119478 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.16474915 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.10847275 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08284455 |
| 25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08075497 |
| 26 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95392561 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.91535811 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91257314 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.90806706 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90774568 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90271549 |
| 32 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.89750667 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.87157507 |
| 34 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86585969 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.86147864 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.82207941 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.81151109 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.81036348 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.78443489 |
| 40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.76682140 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74427785 |
| 42 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73691215 |
| 43 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.71900158 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71436234 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67892072 |
| 46 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.65689223 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65168685 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.61322582 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.60155742 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.59809778 |
| 51 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.58506393 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58348886 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58003953 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54475899 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.54095331 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.52468694 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51250301 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48970605 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48857606 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47342106 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.46542463 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45959679 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45085898 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.44323620 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43433232 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42667135 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42022943 |
| 68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40862144 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40639717 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39091537 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38193238 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38088288 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37171595 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37096588 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34994167 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34644192 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34168172 |
| 78 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33464923 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31304155 |
| 80 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31250373 |
| 81 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.28981550 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28869853 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27038337 |
| 84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26959417 |
| 85 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26745535 |
| 86 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26658852 |
| 87 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.25949879 |
| 88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24729167 |
| 89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24480048 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23922399 |
| 91 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22403358 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21487771 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21050847 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20160216 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18459514 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18261058 |
| 97 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.17666212 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16988745 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15888897 |
| 100 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15240303 |
| 101 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14580850 |
| 102 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14531899 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12996265 |
| 104 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12476846 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11596905 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 1.11300578 |
| 107 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11087662 |
| 108 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10634351 |
| 109 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10498640 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09789384 |
| 111 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.09191434 |
| 112 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08814989 |
| 113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08143060 |
| 114 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.07232628 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06483239 |
| 116 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.06378444 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06092250 |
| 118 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06042675 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05347948 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05281533 |
| 121 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04545344 |
| 122 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04168582 |
| 123 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04098233 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04092024 |
| 125 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04037940 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03581559 |
| 127 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03571636 |
| 128 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02504892 |
| 129 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02371500 |
| 130 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02329063 |
| 131 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01646677 |
| 132 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01358173 |
| 133 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00452314 |
| 134 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99279802 |
| 135 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99002192 |
| 136 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.98785039 |
| 137 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98703649 |
| 138 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98426536 |
| 139 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97726908 |
| 140 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.97453960 |
| 141 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97295375 |
| 142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96441416 |
| 143 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96334374 |
| 144 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94144401 |
| 145 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92142688 |
| 146 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92054618 |
| 147 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91037574 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90494293 |
| 149 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90231926 |
| 150 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89712440 |
| 151 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89574888 |
| 152 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87783539 |
| 153 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87515815 |
| 154 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86230782 |
| 155 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85602869 |
| 156 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.84908440 |
| 157 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.84549533 |
| 158 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.84318533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.70799377 |
| 2 | MP0003724_increased_susceptibility_to | 3.79448814 |
| 3 | MP0005671_abnormal_response_to | 3.73339281 |
| 4 | MP0003436_decreased_susceptibility_to | 3.69600987 |
| 5 | MP0003646_muscle_fatigue | 3.67353507 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.55257973 |
| 7 | MP0000465_gastrointestinal_hemorrhage | 3.24086060 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 3.07498169 |
| 9 | MP0001873_stomach_inflammation | 3.03202020 |
| 10 | MP0003303_peritoneal_inflammation | 2.96930725 |
| 11 | MP0002419_abnormal_innate_immunity | 2.93145703 |
| 12 | MP0009278_abnormal_bone_marrow | 2.73116631 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.50469551 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.47230810 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.39784162 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.38536318 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.32812656 |
| 18 | MP0000749_muscle_degeneration | 2.31506709 |
| 19 | MP0003077_abnormal_cell_cycle | 2.30226656 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.29695592 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 2.28595526 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.24704463 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.21102643 |
| 24 | MP0004084_abnormal_cardiac_muscle | 2.15983520 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.14608155 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.11306038 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.11306038 |
| 28 | MP0005451_abnormal_body_composition | 2.03325737 |
| 29 | MP0004036_abnormal_muscle_relaxation | 2.00897899 |
| 30 | MP0000685_abnormal_immune_system | 1.96657837 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.92138258 |
| 32 | MP0002398_abnormal_bone_marrow | 1.88916229 |
| 33 | MP0009785_altered_susceptibility_to | 1.83927307 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.83177775 |
| 35 | MP0001800_abnormal_humoral_immune | 1.81199090 |
| 36 | MP0002405_respiratory_system_inflammati | 1.80633331 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.78006382 |
| 38 | MP0002722_abnormal_immune_system | 1.76603780 |
| 39 | MP0002933_joint_inflammation | 1.69099192 |
| 40 | MP0000751_myopathy | 1.67860990 |
| 41 | MP0003075_altered_response_to | 1.66370475 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.63617729 |
| 43 | MP0004130_abnormal_muscle_cell | 1.62020324 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.61669437 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.59895073 |
| 46 | MP0002106_abnormal_muscle_physiology | 1.59152399 |
| 47 | MP0008469_abnormal_protein_level | 1.58573587 |
| 48 | MP0003718_maternal_effect | 1.58333693 |
| 49 | MP0009840_abnormal_foam_cell | 1.57299383 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.56948388 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.52819564 |
| 52 | MP0001819_abnormal_immune_cell | 1.52603007 |
| 53 | MP0000716_abnormal_immune_system | 1.50019414 |
| 54 | MP0008260_abnormal_autophagy | 1.49620862 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.48813366 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.48076725 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.48063987 |
| 58 | MP0002723_abnormal_immune_serum | 1.47653661 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.47458265 |
| 60 | MP0001730_embryonic_growth_arrest | 1.45552403 |
| 61 | MP0002269_muscular_atrophy | 1.43150233 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.42161169 |
| 63 | MP0002006_tumorigenesis | 1.41231834 |
| 64 | MP0000343_altered_response_to | 1.39467579 |
| 65 | MP0006082_CNS_inflammation | 1.37427696 |
| 66 | MP0000747_muscle_weakness | 1.37209890 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.37037402 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.36245087 |
| 69 | MP0000858_altered_metastatic_potential | 1.35807577 |
| 70 | MP0003828_pulmonary_edema | 1.31705891 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.30775738 |
| 72 | MP0002429_abnormal_blood_cell | 1.29710687 |
| 73 | MP0009764_decreased_sensitivity_to | 1.29619957 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.28448561 |
| 75 | MP0005166_decreased_susceptibility_to | 1.26818485 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.26607185 |
| 77 | MP0004510_myositis | 1.24763101 |
| 78 | MP0001790_abnormal_immune_system | 1.24510945 |
| 79 | MP0005387_immune_system_phenotype | 1.24510945 |
| 80 | MP0003690_abnormal_glial_cell | 1.22780650 |
| 81 | MP0008932_abnormal_embryonic_tissue | 1.21937206 |
| 82 | MP0005330_cardiomyopathy | 1.21593904 |
| 83 | MP0005025_abnormal_response_to | 1.20429164 |
| 84 | MP0001851_eye_inflammation | 1.20180078 |
| 85 | MP0008057_abnormal_DNA_replication | 1.19851178 |
| 86 | MP0000350_abnormal_cell_proliferation | 1.16659869 |
| 87 | MP0003950_abnormal_plasma_membrane | 1.16386488 |
| 88 | MP0003448_altered_tumor_morphology | 1.16246448 |
| 89 | MP0008058_abnormal_DNA_repair | 1.15750811 |
| 90 | MP0010307_abnormal_tumor_latency | 1.15672947 |
| 91 | MP0003866_abnormal_defecation | 1.14341963 |
| 92 | MP0004947_skin_inflammation | 1.12629445 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 1.11314102 |
| 94 | MP0000490_abnormal_crypts_of | 1.10365118 |
| 95 | MP0000759_abnormal_skeletal_muscle | 1.10272432 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 1.08750525 |
| 97 | MP0005023_abnormal_wound_healing | 1.06050253 |
| 98 | MP0002396_abnormal_hematopoietic_system | 1.03733484 |
| 99 | MP0008004_abnormal_stomach_pH | 1.03042233 |
| 100 | MP0005369_muscle_phenotype | 1.00985527 |
| 101 | MP0004233_abnormal_muscle_weight | 0.99964093 |
| 102 | MP0005380_embryogenesis_phenotype | 0.96851571 |
| 103 | MP0001672_abnormal_embryogenesis/_devel | 0.96851571 |
| 104 | MP0005310_abnormal_salivary_gland | 0.96434331 |
| 105 | MP0000604_amyloidosis | 0.96431904 |
| 106 | MP0001697_abnormal_embryo_size | 0.94310028 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93587821 |
| 108 | MP0001853_heart_inflammation | 0.93175916 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.92815745 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.91451284 |
| 111 | MP0010630_abnormal_cardiac_muscle | 0.91167258 |
| 112 | MP0006054_spinal_hemorrhage | 0.89900613 |
| 113 | MP0005620_abnormal_muscle_contractility | 0.89824740 |
| 114 | MP0004484_altered_response_of | 0.89603012 |
| 115 | MP0005164_abnormal_response_to | 0.87532007 |
| 116 | MP0000733_abnormal_muscle_development | 0.87221380 |
| 117 | MP0001119_abnormal_female_reproductive | 0.85799317 |
| 118 | MP0002139_abnormal_hepatobiliary_system | 0.85574191 |
| 119 | MP0003984_embryonic_growth_retardation | 0.85548256 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.85369452 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85253329 |
| 122 | MP0002088_abnormal_embryonic_growth/wei | 0.83425524 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.82533093 |
| 124 | MP0002127_abnormal_cardiovascular_syste | 0.81488477 |
| 125 | MP0003123_paternal_imprinting | 0.81470513 |
| 126 | MP0002086_abnormal_extraembryonic_tissu | 0.80882764 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.80856368 |
| 128 | MP0005385_cardiovascular_system_phenoty | 0.80577703 |
| 129 | MP0001544_abnormal_cardiovascular_syste | 0.80577703 |
| 130 | MP0002080_prenatal_lethality | 0.80018123 |
| 131 | MP0008007_abnormal_cellular_replicative | 0.78764159 |
| 132 | MP0002972_abnormal_cardiac_muscle | 0.78295861 |
| 133 | MP0003795_abnormal_bone_structure | 0.77942419 |
| 134 | MP0005390_skeleton_phenotype | 0.77909649 |
| 135 | MP0000313_abnormal_cell_death | 0.77608487 |
| 136 | MP0004215_abnormal_myocardial_fiber | 0.77030974 |
| 137 | MP0002132_abnormal_respiratory_system | 0.76883159 |
| 138 | MP0010234_abnormal_vibrissa_follicle | 0.76432871 |
| 139 | MP0001929_abnormal_gametogenesis | 0.76270980 |
| 140 | MP0002653_abnormal_ependyma_morphology | 0.74488904 |
| 141 | MP0004381_abnormal_hair_follicle | 0.73742444 |
| 142 | MP0003183_abnormal_peptide_metabolism | 0.72725145 |
| 143 | MP0004883_abnormal_blood_vessel | 0.72598985 |
| 144 | MP0005395_other_phenotype | 0.71093340 |
| 145 | MP0009763_increased_sensitivity_to | 0.70762011 |
| 146 | MP0002138_abnormal_hepatobiliary_system | 0.70433627 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.70168827 |
| 148 | MP0008874_decreased_physiological_sensi | 0.68614115 |
| 149 | MP0005623_abnormal_meninges_morphology | 0.67793768 |
| 150 | MP0005645_abnormal_hypothalamus_physiol | 0.66867384 |
| 151 | MP0002332_abnormal_exercise_endurance | 0.61005791 |
| 152 | MP0000681_abnormal_thyroid_gland | 0.60557349 |
| 153 | MP0002971_abnormal_brown_adipose | 0.60143643 |
| 154 | MP0005666_abnormal_adipose_tissue | 0.56986731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.33734033 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.76372145 |
| 3 | Nemaline bodies (HP:0003798) | 5.56369064 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.40248843 |
| 5 | T lymphocytopenia (HP:0005403) | 5.08480700 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.89202238 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.81828144 |
| 8 | Fatigue (HP:0012378) | 4.71821907 |
| 9 | Combined immunodeficiency (HP:0005387) | 4.37005711 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 4.31739896 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.25311165 |
| 12 | Exercise-induced myalgia (HP:0003738) | 4.25154598 |
| 13 | Myositis (HP:0100614) | 4.24522647 |
| 14 | Retinal atrophy (HP:0001105) | 4.24241754 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 4.17100197 |
| 16 | Birth length less than 3rd percentile (HP:0003561) | 4.16023154 |
| 17 | Severe combined immunodeficiency (HP:0004430) | 4.10011639 |
| 18 | Obstructive lung disease (HP:0006536) | 3.82003781 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.82003781 |
| 20 | Stomatitis (HP:0010280) | 3.73067358 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.64036097 |
| 22 | Thoracic kyphosis (HP:0002942) | 3.54899716 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.48696309 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 3.45779386 |
| 25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.44512751 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.41313709 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.38936545 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.38936545 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.38936545 |
| 30 | Muscle fiber splitting (HP:0003555) | 3.38494373 |
| 31 | Breast hypoplasia (HP:0003187) | 3.37870271 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 3.28567827 |
| 33 | Abnormality of the lumbar spine (HP:0100712) | 3.25367549 |
| 34 | Myopathic facies (HP:0002058) | 3.21329664 |
| 35 | Abnormality of T cells (HP:0002843) | 3.14239648 |
| 36 | Facial hemangioma (HP:0000329) | 3.11630464 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 3.05038571 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.04962375 |
| 39 | Pustule (HP:0200039) | 3.04866553 |
| 40 | Meningitis (HP:0001287) | 3.04339748 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 3.00724872 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.98418302 |
| 43 | Chest pain (HP:0100749) | 2.95204923 |
| 44 | Optic neuritis (HP:0100653) | 2.93853674 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.93853674 |
| 46 | Thoracolumbar scoliosis (HP:0002944) | 2.92883908 |
| 47 | Rhabdomyolysis (HP:0003201) | 2.91235935 |
| 48 | Abnormality of the columella (HP:0009929) | 2.89333200 |
| 49 | Distal arthrogryposis (HP:0005684) | 2.84091829 |
| 50 | Urticaria (HP:0001025) | 2.81721106 |
| 51 | Areflexia of lower limbs (HP:0002522) | 2.78795676 |
| 52 | Recurrent skin infections (HP:0001581) | 2.78149119 |
| 53 | Myoglobinuria (HP:0002913) | 2.76924505 |
| 54 | Abnormality of the calcaneus (HP:0008364) | 2.73853638 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.72869835 |
| 56 | Vasculitis (HP:0002633) | 2.72631510 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.71852734 |
| 58 | Cellulitis (HP:0100658) | 2.71670262 |
| 59 | Increased IgE level (HP:0003212) | 2.69863790 |
| 60 | Hyporeflexia of lower limbs (HP:0002600) | 2.68809886 |
| 61 | Increased IgM level (HP:0003496) | 2.64817241 |
| 62 | Abnormality of macular pigmentation (HP:0008002) | 2.61299183 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.60202375 |
| 64 | IgG deficiency (HP:0004315) | 2.58114120 |
| 65 | Ulnar deviation of the wrist (HP:0003049) | 2.57464613 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.57443640 |
| 67 | Thyroiditis (HP:0100646) | 2.55812713 |
| 68 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.54958787 |
| 69 | EMG: myopathic abnormalities (HP:0003458) | 2.52489300 |
| 70 | Peritonitis (HP:0002586) | 2.52466712 |
| 71 | Epistaxis (HP:0000421) | 2.52322500 |
| 72 | Encephalitis (HP:0002383) | 2.52079670 |
| 73 | Orchitis (HP:0100796) | 2.49438929 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.48835064 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.48835064 |
| 76 | Cone-rod dystrophy (HP:0000548) | 2.47903505 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.46848419 |
| 78 | Dyschromatopsia (HP:0007641) | 2.42901720 |
| 79 | Abolished electroretinogram (ERG) (HP:0000550) | 2.41018784 |
| 80 | Generalized hypotonia (HP:0001290) | 2.40976815 |
| 81 | Anorexia (HP:0002039) | 2.38782399 |
| 82 | Sudden death (HP:0001699) | 2.38630843 |
| 83 | Abnormality of the thoracic spine (HP:0100711) | 2.37485240 |
| 84 | Autoimmune hemolytic anemia (HP:0001890) | 2.36342140 |
| 85 | Oral leukoplakia (HP:0002745) | 2.36263063 |
| 86 | Petechiae (HP:0000967) | 2.35150118 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.34992255 |
| 88 | Gingival bleeding (HP:0000225) | 2.34140517 |
| 89 | Purpura (HP:0000979) | 2.31607588 |
| 90 | Microcytic anemia (HP:0001935) | 2.30665362 |
| 91 | Pulmonary infiltrates (HP:0002113) | 2.29583466 |
| 92 | Premature ovarian failure (HP:0008209) | 2.28561960 |
| 93 | Colon cancer (HP:0003003) | 2.28401525 |
| 94 | Inflammation of the large intestine (HP:0002037) | 2.27009808 |
| 95 | Increased connective tissue (HP:0009025) | 2.24707341 |
| 96 | Aplastic anemia (HP:0001915) | 2.23763163 |
| 97 | Calcaneovalgus deformity (HP:0001848) | 2.23581617 |
| 98 | Macular degeneration (HP:0000608) | 2.23231354 |
| 99 | Joint swelling (HP:0001386) | 2.22389851 |
| 100 | Long clavicles (HP:0000890) | 2.22302956 |
| 101 | Slow saccadic eye movements (HP:0000514) | 2.21327062 |
| 102 | Biliary tract neoplasm (HP:0100574) | 2.21085005 |
| 103 | Round ear (HP:0100830) | 2.19787182 |
| 104 | Granulocytopenia (HP:0001913) | 2.19211472 |
| 105 | Episodic fever (HP:0001954) | 2.19161289 |
| 106 | Gingivitis (HP:0000230) | 2.17807447 |
| 107 | Frequent falls (HP:0002359) | 2.16570299 |
| 108 | Hemoptysis (HP:0002105) | 2.15708614 |
| 109 | Gastrointestinal inflammation (HP:0004386) | 2.15284023 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.14847356 |
| 111 | Amyloidosis (HP:0011034) | 2.14062132 |
| 112 | Progressive muscle weakness (HP:0003323) | 2.11120004 |
| 113 | Difficulty running (HP:0009046) | 2.09510784 |
| 114 | Metaphyseal cupping (HP:0003021) | 2.09006536 |
| 115 | Abnormality of the calf musculature (HP:0001430) | 2.08288492 |
| 116 | Leukocytosis (HP:0001974) | 2.07860622 |
| 117 | Neck muscle weakness (HP:0000467) | 2.06353298 |
| 118 | Self-mutilation (HP:0000742) | 2.06125133 |
| 119 | Recurrent abscess formation (HP:0002722) | 2.04310805 |
| 120 | Hepatosplenomegaly (HP:0001433) | 2.03918634 |
| 121 | Dysostosis multiplex (HP:0000943) | 2.03525436 |
| 122 | Polycythemia (HP:0001901) | 1.99391035 |
| 123 | Increased serum ferritin (HP:0003281) | 1.99294292 |
| 124 | Hypochromic microcytic anemia (HP:0004840) | 1.98634156 |
| 125 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.98470295 |
| 126 | Pulmonary embolism (HP:0002204) | 1.98375041 |
| 127 | Muscle stiffness (HP:0003552) | 1.97666655 |
| 128 | Increased CSF protein (HP:0002922) | 1.97593154 |
| 129 | Nasal polyposis (HP:0100582) | 1.96587060 |
| 130 | Lipoatrophy (HP:0100578) | 1.94852230 |
| 131 | Cheilitis (HP:0100825) | 1.93134923 |
| 132 | Distal lower limb muscle weakness (HP:0009053) | 1.93045516 |
| 133 | Arterial thrombosis (HP:0004420) | 1.92325108 |
| 134 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91538227 |
| 135 | Subaortic stenosis (HP:0001682) | 1.91234215 |
| 136 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.91234215 |
| 137 | Disinhibition (HP:0000734) | 1.91094452 |
| 138 | Abnormality of T cell physiology (HP:0011840) | 1.90723878 |
| 139 | Spondylolisthesis (HP:0003302) | 1.90093217 |
| 140 | Thrombocytosis (HP:0001894) | 1.88793783 |
| 141 | Deformed tarsal bones (HP:0008119) | 1.88456732 |
| 142 | Chromsome breakage (HP:0040012) | 1.88417565 |
| 143 | 11 pairs of ribs (HP:0000878) | 1.88329767 |
| 144 | Bundle branch block (HP:0011710) | 1.87680732 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.87285015 |
| 146 | Hypochromic anemia (HP:0001931) | 1.86527012 |
| 147 | Breech presentation (HP:0001623) | 1.85283586 |
| 148 | Asymmetric septal hypertrophy (HP:0001670) | 1.85131526 |
| 149 | Recurrent bronchitis (HP:0002837) | 1.84447442 |
| 150 | Chronic diarrhea (HP:0002028) | 1.84048323 |
| 151 | Recurrent viral infections (HP:0004429) | 1.83839319 |
| 152 | Eosinophilia (HP:0001880) | 1.83068498 |
| 153 | Multiple enchondromatosis (HP:0005701) | 1.79532952 |
| 154 | Recurrent fungal infections (HP:0002841) | 1.78564095 |
| 155 | Gastrointestinal infarctions (HP:0005244) | 1.75203119 |
| 156 | Aseptic necrosis (HP:0010885) | 1.75017339 |
| 157 | Neoplasm of the small intestine (HP:0100833) | 1.74847408 |
| 158 | Abnormality of B cell number (HP:0010975) | 1.74602345 |
| 159 | B lymphocytopenia (HP:0010976) | 1.74602345 |
| 160 | Panhypogammaglobulinemia (HP:0003139) | 1.74017214 |
| 161 | Lymphoma (HP:0002665) | 1.72975782 |
| 162 | Rimmed vacuoles (HP:0003805) | 1.71986428 |
| 163 | IgM deficiency (HP:0002850) | 1.71452608 |
| 164 | Abnormality of the fingertips (HP:0001211) | 1.71126099 |
| 165 | Malignant hyperthermia (HP:0002047) | 1.70955132 |
| 166 | Patellar aplasia (HP:0006443) | 1.70887587 |
| 167 | Cellular immunodeficiency (HP:0005374) | 1.70100299 |
| 168 | Bone marrow hypocellularity (HP:0005528) | 1.69335936 |
| 169 | Amaurosis fugax (HP:0100576) | 1.66513995 |
| 170 | Abnormal platelet volume (HP:0011876) | 1.65582261 |
| 171 | Myotonia (HP:0002486) | 1.64514160 |
| 172 | Rectal prolapse (HP:0002035) | 1.64231165 |
| 173 | Difficulty climbing stairs (HP:0003551) | 1.63759456 |
| 174 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.63114447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.64684512 |
| 2 | TXK | 3.51996680 |
| 3 | RIPK4 | 3.41494335 |
| 4 | MAP4K1 | 3.21983115 |
| 5 | TTN | 3.08857314 |
| 6 | ERN1 | 3.01966596 |
| 7 | CDK8 | 2.83496852 |
| 8 | NME2 | 2.77241484 |
| 9 | TESK2 | 2.62071160 |
| 10 | IRAK4 | 2.55665620 |
| 11 | MELK | 2.54782721 |
| 12 | MAP2K6 | 2.50509683 |
| 13 | MAP3K11 | 2.45260663 |
| 14 | CDC7 | 2.44490087 |
| 15 | DAPK2 | 2.39645520 |
| 16 | STK10 | 2.37452000 |
| 17 | BLK | 2.34834249 |
| 18 | KDR | 2.13804108 |
| 19 | ITK | 2.13045771 |
| 20 | MST4 | 2.07446173 |
| 21 | ACVR1B | 2.06624730 |
| 22 | NLK | 2.03971162 |
| 23 | ZAP70 | 1.99877462 |
| 24 | BUB1 | 1.87977756 |
| 25 | FES | 1.86469017 |
| 26 | TNK2 | 1.79831648 |
| 27 | PKN2 | 1.74270669 |
| 28 | WEE1 | 1.66672674 |
| 29 | TTK | 1.62946707 |
| 30 | EEF2K | 1.61569942 |
| 31 | SMG1 | 1.61466235 |
| 32 | MAP3K7 | 1.60861136 |
| 33 | CLK1 | 1.49608631 |
| 34 | NEK2 | 1.43448940 |
| 35 | TAOK3 | 1.43337437 |
| 36 | JAK3 | 1.42356142 |
| 37 | CDK4 | 1.42333288 |
| 38 | NME1 | 1.40279976 |
| 39 | NEK1 | 1.38338753 |
| 40 | CDK9 | 1.33855898 |
| 41 | MAP3K14 | 1.28254177 |
| 42 | EPHB1 | 1.25707833 |
| 43 | MAP3K1 | 1.25481466 |
| 44 | FGR | 1.25072517 |
| 45 | GRK6 | 1.22282963 |
| 46 | PLK4 | 1.21451984 |
| 47 | LCK | 1.19758577 |
| 48 | BRSK2 | 1.16560040 |
| 49 | RPS6KB2 | 1.13657176 |
| 50 | RPS6KL1 | 1.12581113 |
| 51 | RPS6KC1 | 1.12581113 |
| 52 | TAOK2 | 1.11669751 |
| 53 | STK38L | 1.10601213 |
| 54 | LYN | 1.10156190 |
| 55 | JAK2 | 1.07862424 |
| 56 | CDK19 | 1.05489816 |
| 57 | PLK1 | 1.04214826 |
| 58 | DYRK1B | 1.00768770 |
| 59 | CSF1R | 1.00459889 |
| 60 | RPS6KA6 | 1.00325295 |
| 61 | HIPK2 | 0.98356287 |
| 62 | TESK1 | 0.94671031 |
| 63 | TGFBR2 | 0.94410697 |
| 64 | TRIB3 | 0.93895727 |
| 65 | STK24 | 0.93350889 |
| 66 | AURKB | 0.91742600 |
| 67 | PRKD2 | 0.91628079 |
| 68 | EIF2AK1 | 0.91077252 |
| 69 | BRSK1 | 0.88601449 |
| 70 | IKBKB | 0.86363307 |
| 71 | MUSK | 0.85602400 |
| 72 | DMPK | 0.84897099 |
| 73 | MAP3K8 | 0.84623392 |
| 74 | KIT | 0.83934324 |
| 75 | STK11 | 0.83712508 |
| 76 | PIM1 | 0.83019678 |
| 77 | MATK | 0.82718338 |
| 78 | CDK6 | 0.81019810 |
| 79 | TYK2 | 0.78094806 |
| 80 | EPHA2 | 0.76843622 |
| 81 | LRRK2 | 0.76340755 |
| 82 | PIK3CG | 0.75259829 |
| 83 | DAPK1 | 0.75111251 |
| 84 | MAP2K2 | 0.72816579 |
| 85 | YES1 | 0.72293705 |
| 86 | CSK | 0.71695491 |
| 87 | RAF1 | 0.71248371 |
| 88 | RPS6KA4 | 0.71009162 |
| 89 | MAPKAPK3 | 0.70267657 |
| 90 | MAPK12 | 0.69743529 |
| 91 | STK4 | 0.69557719 |
| 92 | ERBB4 | 0.69492415 |
| 93 | SIK2 | 0.69201072 |
| 94 | TAOK1 | 0.67933951 |
| 95 | PRKCH | 0.67073793 |
| 96 | MARK3 | 0.65399346 |
| 97 | TEC | 0.64926363 |
| 98 | LIMK1 | 0.63880594 |
| 99 | RPS6KA2 | 0.63355694 |
| 100 | KSR2 | 0.61399984 |
| 101 | AURKA | 0.59728770 |
| 102 | IKBKE | 0.59051989 |
| 103 | CAMKK2 | 0.58947337 |
| 104 | PTK2B | 0.58387324 |
| 105 | PRKG2 | 0.57583719 |
| 106 | PDK1 | 0.57148025 |
| 107 | JAK1 | 0.56990023 |
| 108 | PDPK1 | 0.56966875 |
| 109 | DAPK3 | 0.56266860 |
| 110 | IRAK2 | 0.55437428 |
| 111 | FGFR4 | 0.54824957 |
| 112 | FGFR1 | 0.54489992 |
| 113 | TRPM7 | 0.52815383 |
| 114 | FYN | 0.50942651 |
| 115 | LATS2 | 0.50298917 |
| 116 | CHEK1 | 0.49898506 |
| 117 | RIPK1 | 0.49367420 |
| 118 | PAK4 | 0.49164085 |
| 119 | SYK | 0.48292541 |
| 120 | MAPK11 | 0.48239068 |
| 121 | MAPK7 | 0.46556977 |
| 122 | BCKDK | 0.45877600 |
| 123 | TBK1 | 0.45840484 |
| 124 | PRPF4B | 0.45828699 |
| 125 | MARK2 | 0.44652593 |
| 126 | MAP2K4 | 0.44174406 |
| 127 | BRAF | 0.43917084 |
| 128 | TNIK | 0.43805588 |
| 129 | PDK3 | 0.43443607 |
| 130 | PDK4 | 0.43443607 |
| 131 | CHEK2 | 0.43165245 |
| 132 | ATR | 0.42994994 |
| 133 | BTK | 0.42902071 |
| 134 | HCK | 0.41457642 |
| 135 | GRK7 | 0.41450790 |
| 136 | MAP3K3 | 0.40716880 |
| 137 | MAP3K13 | 0.40164447 |
| 138 | ALK | 0.38853231 |
| 139 | PTK6 | 0.37641703 |
| 140 | IRAK1 | 0.37452835 |
| 141 | SIK3 | 0.37077542 |
| 142 | CAMKK1 | 0.36376222 |
| 143 | ATM | 0.36260836 |
| 144 | MYLK | 0.36052695 |
| 145 | PHKG2 | 0.36049205 |
| 146 | PHKG1 | 0.36049205 |
| 147 | CDK12 | 0.34834741 |
| 148 | RPS6KA1 | 0.34246822 |
| 149 | ZAK | 0.33598408 |
| 150 | MAP3K5 | 0.33351693 |
| 151 | MAPK10 | 0.32751323 |
| 152 | LATS1 | 0.32639079 |
| 153 | MAP3K6 | 0.32344819 |
| 154 | IRAK3 | 0.30598197 |
| 155 | PRKCQ | 0.30292634 |
| 156 | MAP2K3 | 0.29681010 |
| 157 | MAPK4 | 0.29400855 |
| 158 | CDK2 | 0.29259512 |
| 159 | PRKCD | 0.29193774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.44741159 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.67943930 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.86639032 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.77220428 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76762959 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.62863574 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.53609196 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51653982 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.46044296 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.41913840 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.37701497 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.31090454 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.25640258 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20011255 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 2.12511524 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10982292 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 2.05979788 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.04038690 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.99589636 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91219137 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.83671212 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.81905683 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.79097313 |
| 24 | RNA transport_Homo sapiens_hsa03013 | 1.73453119 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71191646 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.70013359 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.69292027 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.68890319 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.67809084 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.64618394 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.60243019 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.60184391 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.47184678 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46765995 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43087582 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42181601 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.38622755 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35505669 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33328286 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.27183834 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26929661 |
| 42 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21560048 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19583999 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19137939 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18439180 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18073057 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.14422144 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11609545 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07630869 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.06108472 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05294213 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04506686 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.03857068 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02730089 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99887856 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99470523 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99362712 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98591108 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98385615 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98048400 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.97971604 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96826868 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.94369555 |
| 64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.94145110 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93369651 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.93082611 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90650881 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90536934 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90242589 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.89131263 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88824148 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88822458 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88072688 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86351378 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.84746433 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83572140 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82239791 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81459949 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79956973 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79145683 |
| 81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78815024 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76436226 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75935432 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75200952 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71769044 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70741362 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69075376 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.67380808 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66875328 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.66356840 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62764415 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61204528 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60847630 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60499437 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58791132 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58395989 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.58317290 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58145551 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57542256 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56506365 |
| 101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56313204 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.55670009 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55526162 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.52516387 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52228751 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50269185 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.49200010 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49087324 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49030561 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.48634212 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48574033 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.48533067 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47426988 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46382798 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46136478 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45332369 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43571672 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43498194 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42791256 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41333645 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.40960158 |
| 122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39897574 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39179156 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38618504 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38435917 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37898785 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36730067 |
| 128 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36657176 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.36486888 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36210450 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36033805 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34124271 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33787839 |
| 134 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33114106 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32326290 |
| 136 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31843800 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31591778 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31124862 |
| 139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30596187 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29832208 |
| 141 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28933811 |
| 142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28265644 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27692470 |
| 144 | Tight junction_Homo sapiens_hsa04530 | 0.27296237 |
| 145 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27004843 |
| 146 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.26395608 |
| 147 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.25834420 |
| 148 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25600330 |
| 149 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25598227 |
| 150 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25485585 |
| 151 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24788367 |
| 152 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24505102 |
| 153 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23191170 |
| 154 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23159829 |
| 155 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.21786212 |
| 156 | Focal adhesion_Homo sapiens_hsa04510 | 0.19644577 |

